RXQ Compounding LLC FDA Record
- Latest inspection OAI · Aug 8, 2017
- Last warning letter 2016
RXQ Compounding LLC has 88 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to RXQ Compounding LLC, the most recent on May 19, 2016. FDA has published 3 Form 483s for RXQ Compounding LLC.
- Latest recall
- D-1711-2019 · Class II · Jun 19, 2019
- Latest inspection
- Aug 8, 2017 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 88 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 0 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 2 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
RXQ Compounding LLC: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 86 | 0 |
| 2018 | 0 | 0 | 0 | 1 | 0 |
| 2017 | 1 | 1 | 0 | 1 | 0 |
Reviewing RXQ Compounding LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check RXQ Compounding LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
RXQ Compounding LLC FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| May 19, 2016 · Record page |
RXQ Compounding LLC Form 483s
| Date | Document | FEI |
|---|---|---|
| Jun 6, 2019 · Document on fda.gov | 483 | 3011509553 |
| Oct 25, 2017 · Document on fda.gov | 483 | 3011509553 |
| Nov 8, 2015 · Document on fda.gov | 483 | 3011509553 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1711-2019 | Class II | TRAVASOL 10% (AMINO ACID) INJECTION SOLUTION, 50 ML per Vial, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1666-2019 | Class II | HYDROXOCOBALAMIN 1000 MCG/ML (PFV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9… | Jun 19, 2019 |
| D-1657-2019 | Class II | EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West… | Jun 19, 2019 |
| D-1679-2019 | Class II | METHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340 West State Street… | Jun 19, 2019 |
| D-1662-2019 | Class II | GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street… | Jun 19, 2019 |
| D-1713-2019 | Class II | TURBO DROPS (PHEN 0.625%/CYCLO 0.25%/TROP 0.25%/KETO 0.125%) OPHTH SOLN, 0.4 ML per Syringe, RXQ… | Jun 19, 2019 |
| D-1659-2019 | Class II | FENTANYL 2MCG/ML BUPIVACAINE 0.125% IN NACL 0.9% SRY C-II, 50ML per syringe (C-II) RXQ Compounding… | Jun 19, 2019 |
| D-1704-2019 | Class II | SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1670-2019 | Class II | KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per… | Jun 19, 2019 |
| D-1698-2019 | Class II | PROCAINE HCL 8% (PFV) INJECTABLE, 10ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9… | Jun 19, 2019 |
| D-1690-2019 | Class II | ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street… | Jun 19, 2019 |
| D-1677-2019 | Class II | METHYLCOBALAMIN 10MG/ML INJECTABLE SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1674-2019 | Class II | MAGNESIUM CHLORIDE HEXAHYDRATE (MDV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1699-2019 | Class II | PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH… | Jun 19, 2019 |
| D-1672-2019 | Class II | LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street… | Jun 19, 2019 |
| D-1656-2019 | Class II | EPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State Street, Unit 9… | Jun 19, 2019 |
| D-1634-2019 | Class II | Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1665-2019 | Class II | HYDROMORPHONE 0.2MG/ML IN NACL 0.9% SYR (C-II) , [a) 50 ML NDC 70731-0114-89; b) 55 ML NDC… | Jun 19, 2019 |
| D-1675-2019 | Class II | MAGNESIUM CHLORIDE HEXAHYDRATE (PFV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State… | Jun 19, 2019 |
| D-1701-2019 | Class II | RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding, 340 West State… | Jun 19, 2019 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 8, 2017 | Albany, OH | Drugs | Official Action Indicated (OAI) | 3011509553 |
| Sep 21, 2015 | Albany, OH | Drugs | Official Action Indicated (OAI) | 3011509553 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under RXQ Compounding LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3011509553 | Albany, OH | 2 | Aug 8, 2017 |
RXQ Compounding LLC and the FDA: common questions
Has RXQ Compounding LLC received an FDA warning letter?
Yes. FDA has issued 1 warning letter to RXQ Compounding LLC. The most recent is dated May 19, 2016.
Has RXQ Compounding LLC received an FDA Form 483?
FDA has published 3 Form 483s for RXQ Compounding LLC in its reading room, the most recent dated Jun 6, 2019. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect RXQ Compounding LLC?
The most recent FDA inspection on file ended Aug 8, 2017 at Albany, OH and was classified OAI. FDA has 2 inspections of RXQ Compounding LLC on file, 2 of them classified OAI (official action indicated).
Has RXQ Compounding LLC had an FDA recall?
Yes. RXQ Compounding LLC has 88 FDA recalls on record. The most recent started Jun 19, 2019.
Need more than this page shows? Ask about RXQ Compounding LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.